Eliquis Tablet, Film Coated
NDC Package 55154-0613-0
Package Information
Eliquis (apixaban) tablets is apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. This formulation utilizes a tablet, film coated delivery system. Marketed by Cardinal Health 107, Llc, this product is identified by NDC 55154-0613 and is authorized under FDA application NDA202155.
Identification & Billing
- RxCUI: 1364435 - apixaban 2.5 MG Oral Tablet
- RxCUI: 1364441 - Eliquis 2.5 MG Oral Tablet
- RxCUI: 1364441 - apixaban 2.5 MG Oral Tablet [Eliquis]
- RxCUI: 1364445 - apixaban 5 MG Oral Tablet
- RxCUI: 1364447 - Eliquis 5 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 55154 - Cardinal Health 107, Llc
- 55154-0613 - Eliquis
- 55154-0613-0 - 10 BLISTER PACK in 1 BAG / 1 TABLET, FILM COATED in 1 BLISTER PACK
- 55154-0613 - Eliquis
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (55154-0613). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55154-0613-0 identifies a specific commercial package of 10 blister pack in 1 bag / 1 tablet, film coated in 1 blister pack of Eliquis, a human prescription drug labeled by Cardinal Health 107, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 10 billable units per package. This tablet, film coated is formulated for oral use and contains apixaban as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cardinal Health 107, Llc on December 28, 2012. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood.
How is this Cardinal Health 107, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55154061300. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 10 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.